1. Home
  2. LKFT

as of 10-23-2026 3:41pm EST

$31.70
+$0.30
+0.96%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.

Founded: 1999 Country:
Belgium
Belgium
Employees: N/A City: N/A
Market Cap: 2.0B IPO Year: 2007
Target Price: $30.21 AVG Volume (30 days): 256.8K
Analyst Decision: Hold Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $25.68 - $32.41 Next Earning Date: 11-11-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): -89.46% Revenue Growth (next year): -27.81%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered LKFT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Precision: 0.00%
0.00%
AI Precision

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: